According to our results, when combined with a safe and effective micellar platform, NF-κB p65 siRNA is efficiently targeted and delivered to the arthritis site, avoiding off-target toxicity to a great extent, thereby specifically inhibiting arthritis. This evidence concerns the gene NFKB1 and arthritic joint disease.